Inventor · disambiguated record
Ralph Alderson
Also filed as: ALDERSON RALPH · ALDERSON RALPH F · ALDERSON RALPH FROMAN
12 granted patents·16 pending applications·214 citations·filing 1996–2023
92Inventor score
Top patents by PatentIndex Score
28 records- 0197US9822181B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2014·Granted Nov 21, 2017·62 cites·32 claims
- 0294US10787521B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2017·Granted Sep 29, 2020·7 cites·18 claims
- 0391US6605441B1Antibodies against fibroblast growth factor 11HUMAN GENOME SCIENCES INC·Filed 2000·Granted Aug 12, 2003·23 cites·104 claims
- 0489US11685781B2Variant CD3-binding domains and their use in combination therapies for the treatment of diseaseMACROGENICS INC·Filed 2019·Granted Jun 27, 2023·4 cites·33 claims
- 0587US6593112B1Polynucleotides encoding fibroblast growth factor 15HUMAN GENOME SCIENCES INC·Filed 2000·Granted Jul 15, 2003·11 cites·67 claims
- 0682US7524501B2Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodiesHUMAN GENOME SCIENCES INC·Filed 2005·Granted Apr 28, 2009·15 cites·11 claims
- 0782US6673344B1Antibodies to human CKβ-10/MCP-4HUMAN GENOME SCIENCES INC·Filed 2000·Granted Jan 6, 2004·40 cites·54 claims
- 0877US7223724B1Use of vascular endothelial growth factor to treat photoreceptor cellsHUMAN GENOME SCIENCES INC·Filed 2000·Granted May 29, 2007·28 cites·20 claims
- 0975US6174995B1Human chemokines, CKβ4 and CKβ10/MCP-4Filed 1996·Granted Jan 16, 2001·22 cites·30 claims
- 1073US6391589B1Human chemokine beta-10 mutant polypeptidesHUMAN GENOME SCIENCES INC·Filed 2000·Granted May 21, 2002·2 cites·50 claims
- 1172US2024043537A1Variant CD3-Binding Domains and Their Use in Combination Therapies for the Treatment of DiseaseMACROGENICS INC·Filed 2023·Application pending·0 cites
- 1265US2021047426A1Bi-Specific Monovalent Diabodies That are Capable of Binding CD123 and CD3, and Uses ThereofMACROGENICS INC·Filed 2020·Application pending·0 cites
- 1361US2007238644A1Human Chemokines CKBeta-4 and CKBeta-10/MCP-4HUMAN GENOME SCIENCES INC·Filed 2006·Application pending·0 cites
- 1457US6936688B2Human chemokine beta-10 mutant polypeptidesSMITHKLINE BEECHAM CORP·Filed 2002·Granted Aug 30, 2005·0 cites·18 claims
- 1557US2004048271A1Fibroblast growth factor 11HUMAN GENOME SCIENCES INC·Filed 2003·Application pending·0 cites
- 1656US2005026838A1Fibroblast Growth Factor-13HUMAN GENOME SCIENCES INC·Filed 2004·Application pending·0 cites
- 1755US2005019824A1Fibroblast Growth Factor-10HUMAN GENOME SCIENCES INC·Filed 2004·Application pending·0 cites
- 1853US2004043024A1Fibroblast growth factor-14HUMAN GENOME SCIENCES INC·Filed 2003·Application pending·0 cites
- 1951US2007178108A1Colon Specific Gene and Protein and CancerHUMAN GENOME SCIENCES INC·Filed 2007·Application pending·0 cites
- 2048US2003171319A1Human chemokine beta-10 mutant polypeptidesFiled 2002·Application pending·0 cites
- 2147US2022213203A1Dosing Regimens of Bispecific CD123 x CD3 Diabodies in the Treatment of Hematologic MalignanciesMACROGENICS INC·Filed 2020·Application pending·0 cites
- 2244US2004254101A1Colon specific gene and protein and cancerHUMAN GENOME SCIENCES INC·Filed 2002·Application pending·0 cites
- 2341US2017233472A1ROR1-Binding Molecules, and Methods of Use ThereofMACROGENICS INC·Filed 2017·Application pending·0 cites
- 2441US2020255524A1Combination therapyMACROGENICS INC·Filed 2017·Application pending·0 cites
- 2540US2019002563A1Bispecific Monovalent Diabodies That are Capable of Binding B7-H3 and CD3, and Uses ThereofMACROGENICS INC·Filed 2016·Application pending·0 cites
- 2638US2009317394A1Vascular endothelial growth factor-2HUMAN GENOME SCIENCES INC·Filed 2008·Application pending·0 cites
- 2738US2021061911A1Dosing Regiments of Bi-Specific CD123 x CD3 Diabodies in the Treatment of Hematologic MalignanciesMACROGENICS INC·Filed 2017·Application pending·0 cites
- 2832US7138498B2Antibodies to MCP-4HUMAN GENOME SCIENCES INC·Filed 2003·Granted Nov 21, 2006·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →